Clinical Trial: Evaluate the Efficacy and Safety of N02RS1 in Patient With Acute Bronchitis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Multi Center, Randomized, Double-blind, Placebo-controlled, Parallel, Phase 2b Clinical Trial to Evaluate the Efficacy and Safety of N02RS1 in Patients With Acute Bronchitis

Brief Summary: A multi center, randomized, double-blind, placebo-controlled, parallel, phase 2b clinical trial to evaluate the efficacy and safety of N02RS1 in patients with acute bronchitis

Detailed Summary: Suitable subjects randomized to the experimental or control group. The subjects eat IP during 7days. Visit 3(3 days) evaluate BSS through phone call and visit 4(8 days) evaluate efficacy and safety.
Sponsor: PharmaKing

Current Primary Outcome: BSS(Bronchitis Severity Score) score variation compared to baseline after 7 days [ Time Frame: Visit 1(-3days, screening), 2(0day, randomization), 3(3days), 4(8days) ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: PharmaKing

Dates:
Date Received: December 8, 2015
Date Started: December 2015
Date Completion:
Last Updated: March 29, 2016
Last Verified: March 2016